Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Recurrence"" wg kryterium: Temat


Tytuł:
Two-centre experience in the treatment of thyroglossal duct remnants using the modified muscle-sparing Sistrunk technique.
Autorzy:
Pupić-Bakrač J; Department of Otorhinolaryngology and Maxillofacial Surgery, General Hospital Zadar, Zadar, Croatia. Electronic address: .
Lasić V; Department of Paediatric Surgery, University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina; School of Medicine, University of Mostar, Mostar, Bosnia and Herzegovina.
Matoc L; Department of Maxillofacial Surgery, University Hospital Centre Zagreb, Zagreb, Croatia.
Knežević P; School of Medicine, University of Mostar, Mostar, Bosnia and Herzegovina; Department of Maxillofacial and Oral Surgery, Dubrava University Hospital, Zagreb, Croatia; School of Dentistry, University of Zagreb, Zagreb, Croatia.
Skitarelić N; Department of Otorhinolaryngology and Maxillofacial Surgery, General Hospital Zadar, Zadar, Croatia; Department of Health Studies, University of Zadar, Zadar, Croatia.
Novaković J; School of Medicine, University of Mostar, Mostar, Bosnia and Herzegovina; Department of Otorhinolaryngology, General Hospital Zabok, Bračak, Croatia.
Pokaż więcej
Źródło:
International journal of oral and maxillofacial surgery [Int J Oral Maxillofac Surg] 2023 Jul; Vol. 52 (7), pp. 768-774. Date of Electronic Publication: 2023 Feb 08.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*
Thyroglossal Cyst*/surgery
Humans ; Male ; Female ; Child ; Adolescent ; Young Adult ; Adult ; Middle Aged ; Retrospective Studies ; Muscles ; Electrocoagulation ; Recurrence
Czasopismo naukowe
Tytuł:
Factors affecting Naseptin treatment success - A prospective cohort study.
Autorzy:
Garry S; Department of Otolaryngology, Children's Health Ireland at Temple Street, Dublin 1, Ireland; Department of Surgery, Royal College of Surgeons, Dublin 2, Ireland. Electronic address: .
Wauchope J; Department of Otolaryngology, Children's Health Ireland at Temple Street, Dublin 1, Ireland; Department of Surgery, Royal College of Surgeons, Dublin 2, Ireland.
Hintze JM; Department of Surgery, Royal College of Surgeons, Dublin 2, Ireland.
Ryan EJ; Department of Surgery, Royal College of Surgeons, Dublin 2, Ireland.
O'Cathain E; Department of Otolaryngology, Children's Health Ireland at Temple Street, Dublin 1, Ireland; Department of Surgery, Royal College of Surgeons, Dublin 2, Ireland.
Heffernan CB; Department of Otolaryngology, Children's Health Ireland at Temple Street, Dublin 1, Ireland; Department of Surgery, Royal College of Surgeons, Dublin 2, Ireland.
Pokaż więcej
Źródło:
International journal of pediatric otorhinolaryngology [Int J Pediatr Otorhinolaryngol] 2023 Aug; Vol. 171, pp. 111620. Date of Electronic Publication: 2023 Jun 17.
Typ publikacji:
Journal Article
MeSH Terms:
Epistaxis*/surgery
Neoplasm Recurrence, Local*
Child ; Humans ; Prospective Studies ; Chlorhexidine/therapeutic use ; Cautery ; Recurrence
Czasopismo naukowe
Tytuł:
Utilising alternative cystoscopic schedules to minimise cost and patient burden after trimodality therapy for muscle-invasive bladder cancer.
Autorzy:
Krishnatry R; Department of Radiation Oncology, Tata Memorial Centre and Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Homi Bhabha National Institute (HBNI), Mumbai, India.
Maitre P; Department of Radiation Oncology, Tata Memorial Centre and Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Homi Bhabha National Institute (HBNI), Mumbai, India.
Kumar A; Department of Radiation Oncology, Tata Memorial Centre and Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Homi Bhabha National Institute (HBNI), Mumbai, India.
Telkhade T; Department of Radiation Oncology, Tata Memorial Centre and Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Homi Bhabha National Institute (HBNI), Mumbai, India.
Bakshi G; Department of Surgical Oncology, Tata Memorial Centre and Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Homi Bhabha National Institute (HBNI), Mumbai, India.
Prakash G; Department of Surgical Oncology, Tata Memorial Centre and Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Homi Bhabha National Institute (HBNI), Mumbai, India.
Pal M; Department of Surgical Oncology, Tata Memorial Centre and Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Homi Bhabha National Institute (HBNI), Mumbai, India.
Joshi A; Department of Medical Oncology, Tata Memorial Centre and Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Homi Bhabha National Institute (HBNI), Mumbai, India.
Menon S; Department of Pathology, Tata Memorial Centre and Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Homi Bhabha National Institute (HBNI), Mumbai, India.
Murthy V; Department of Radiation Oncology, Tata Memorial Centre and Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Homi Bhabha National Institute (HBNI), Mumbai, India.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 May; Vol. 12 (10), pp. 11305-11314. Date of Electronic Publication: 2023 Mar 25.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*/pathology
Urinary Bladder Neoplasms*/diagnosis
Urinary Bladder Neoplasms*/therapy
Urinary Bladder Neoplasms*/pathology
Humans ; Urinary Bladder/diagnostic imaging ; Urinary Bladder/pathology ; Sensitivity and Specificity ; Recurrence
Czasopismo naukowe
Tytuł:
Mitigating fear of cancer recurrence.
Autorzy:
Sorscher S; Wake Forest School of Medicine, One Medical Center Blvd, Winston-Salem,, NC 27157, USA. .
Pokaż więcej
Źródło:
Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Apr; Vol. 198 (2), pp. 401. Date of Electronic Publication: 2023 Feb 03.
Typ publikacji:
Letter; Comment
MeSH Terms:
Neoplasm Recurrence, Local*/prevention & control
Breast Neoplasms*
Humans ; Female ; Fear ; Survivors ; Recurrence ; Quality of Life
Opinia redakcyjna
Tytuł:
Nationwide cohort study identifies clinical outcomes of angioectasia in patients with acute hematochezia.
Autorzy:
Kobayashi M; Division of Endoscopic Center, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan.
Akiyama S; Department of Gastroenterology, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Narasaka T; Division of Endoscopic Center, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan. .; Department of Gastroenterology, University of Tsukuba, Tsukuba, Ibaraki, Japan. .
Kobayashi K; Department of Gastroenterology, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan.
Yamauchi A; Department of Gastroenterology and Hepatology, Kitano Hospital, Tazuke Kofukai Medical Research Institute, Osaka, Japan.
Yamada A; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Omori J; Department of Gastroenterology, Nippon Medical School, Graduate School of Medicine, Tokyo, Japan.
Ikeya T; Department of Gastroenterology, St. Luke's International University, Tokyo, Japan.
Aoyama T; Department of Gastroenterology, Hiroshima City Asa Citizens Hospital, Hiroshima, Japan.
Tominaga N; Department of Gastroenterology, Saga-Ken Medical Centre Koseikan, Saga, Japan.
Sato Y; Division of Gastroenterology and Hepatology, Department of Internal Medicine, St Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Kishino T; Department of Gastroenterology and Hepatology, Center for Digestive and Liver Diseases, Nara City Hospital, Nara, Japan.
Ishii N; Department of Gastroenterology, Tokyo Shinagawa Hospital, Tokyo, Japan.
Sawada T; Department of Endoscopy, Nagoya University Hospital, Nagoya, Aichi, Japan.
Murata M; Department of Gastroenterology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
Takao A; Department of Gastroenterology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
Mizukami K; Department of Gastroenterology, Oita University, Oita, Japan.
Kinjo K; Department of Gastroenterology, Fukuoka University Chikushi Hospital, Fukuoka, Japan.
Fujimori S; Department of Gastroenterology, Chiba Hokusoh Hospital, Nippon Medical School, Chiba, Japan.
Uotani T; Department of Gastroenterology, Japanese Red Cross Shizuoka Hospital, Shizuoka, Japan.
Fujita M; Division of Endoscopy and Ultrasonography, Department of Clinical Pathology and Laboratory Medicine, Kawasaki Medical School General Medical Center, Okayama, Japan.
Sato H; Division of Gastroenterology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
Suzuki S; Department of Gastroenterology and Hepatology, Center for Digestive Disease and Division of Endoscopy, University of Miyazaki Hospital, Miyazaki, Japan.
Hayasaka J; Department of Gastroenterology, Toranomon Hospital, Tokyo, Japan.
Funabiki T; Department of Emergency Medicine, Fujita Health University Hospital, Aichi, Japan.; Emergency and Critical Care Center, Saiseikai Yokohama Tobu Hospital, Yokohama, Kanagawa, Japan.
Kinjo Y; Department of Gastroenterology, Naha City Hospital, Naha, Okinawa, Japan.
Mizuki A; Department of Internal Medicine, Tokyo Saiseikai Central Hospital, Tokyo, Japan.
Kiyotoki S; Department of Gastroenterology, Shuto General Hospital, Yanai, Yamaguchi, Japan.
Mikami T; Division of Endoscopy, Hirosaki University Hospital, Aomori, Japan.
Gushima R; Department of Gastroenterology and Hepatology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Fujii H; Department of Gastroenterology and Hepatology, National Hospital Organization Fukuokahigashi Medical Center, Fukuoka, Japan.
Fuyuno Y; Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Gunji N; Department of Gastroenterology, Fukushima Medical University, Fukushima, Japan.
Toya Y; Division of Gastroenterology, Department of Internal Medicine, Iwate Medical University, Morioka, Iwate, Japan.
Narimatsu K; Department of Internal Medicine, National Defense Medical College, Saitama, Japan.
Manabe N; Division of Endoscopy and Ultrasonography, Department of Clinical Pathology and Laboratory Medicine, Kawasaki Medical School, Okayama, Japan.
Nagaike K; Department of Gastroenterology and Hepatology, Suita Municipal Hospital, Osaka, Japan.
Kinjo T; Department of Endoscopy, University of the Ryukyus Hospital, Okinawa, Japan.
Sumida Y; Department of Gastroenterology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
Funakoshi S; Department of Gastroenterological Endoscopy, Fukuoka University Hospital, Fukuoka, Japan.
Kobayashi K; Department of Gastroenterology, School of Medicine, Kitasato University, Sagamihara, Kanagawa, Japan.
Matsuhashi T; Department of Gastroenterology and Neurology, Akita University Graduate School of Medicine, Akita, Japan.
Komaki Y; Digestive and Lifestyle Diseases, and Hygiene and Health Promotion Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Miki K; Department of Gastroenterological Endoscopy, Tokyo Medical University, Tokyo, Japan.
Watanabe K; Department of Gastroenterology and Hepatology, National Center for Global Health and Medicine, Tokyo, Japan.
Tsuchiya K; Department of Gastroenterology, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Kaise M; Department of Gastroenterology, Nippon Medical School, Graduate School of Medicine, Tokyo, Japan.
Nagata N; Department of Gastroenterological Endoscopy, Tokyo Medical University, Tokyo, Japan.; Department of Gastroenterology and Hepatology, National Center for Global Health and Medicine, Tokyo, Japan.
Pokaż więcej
Źródło:
Journal of gastroenterology [J Gastroenterol] 2023 Apr; Vol. 58 (4), pp. 367-378. Date of Electronic Publication: 2022 Dec 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Neoplasm Recurrence, Local*
Gastrointestinal Hemorrhage*/epidemiology
Gastrointestinal Hemorrhage*/etiology
Gastrointestinal Hemorrhage*/therapy
Humans ; Female ; Cohort Studies ; Retrospective Studies ; Risk Factors ; Dilatation, Pathologic ; Recurrence
Czasopismo naukowe
Tytuł:
Quiescent Cancer Cells-A Potential Therapeutic Target to Overcome Tumor Resistance and Relapse.
Autorzy:
Lindell E; Department of Immunology, Genetics and Pathology, Uppsala University, SE-751 85 Uppsala, Sweden.
Zhong L; Department of Immunology, Genetics and Pathology, Uppsala University, SE-751 85 Uppsala, Sweden.
Zhang X; Department of Immunology, Genetics and Pathology, Uppsala University, SE-751 85 Uppsala, Sweden.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Feb 13; Vol. 24 (4). Date of Electronic Publication: 2023 Feb 13.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Neoplasm Recurrence, Local*/drug therapy
Resting Phase, Cell Cycle*/drug effects
Humans ; Cell Cycle ; Cell Division ; Recurrence
Czasopismo naukowe
Tytuł:
Risk Factors of Second Local Recurrence in Surgically Treated Recurrent Brain Metastases: An Exploratory Analysis.
Autorzy:
Tewarie IA; Computational Neurosciences Outcomes Center, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Department of Neurosurgery, Leiden University Medical Center, Leiden, The Netherlands; School of Pharmacy, Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts, USA; Department of Neurosurgery, Haaglanden Medical Center, The Hague, The Netherlands.
Hulsbergen AFC; Computational Neurosciences Outcomes Center, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Department of Neurosurgery, Leiden University Medical Center, Leiden, The Netherlands; School of Pharmacy, Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts, USA; Department of Neurosurgery, Haaglanden Medical Center, The Hague, The Netherlands.
Jessurun CAC; Computational Neurosciences Outcomes Center, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Department of Neurosurgery, Leiden University Medical Center, Leiden, The Netherlands; School of Pharmacy, Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts, USA; Department of Neurosurgery, Haaglanden Medical Center, The Hague, The Netherlands.
Rendon LF; Computational Neurosciences Outcomes Center, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Mekary RA; Computational Neurosciences Outcomes Center, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; School of Pharmacy, Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts, USA.
Smith TR; Computational Neurosciences Outcomes Center, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Broekman MLD; Computational Neurosciences Outcomes Center, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Department of Neurosurgery, Leiden University Medical Center, Leiden, The Netherlands; School of Pharmacy, Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts, USA; Department of Neurosurgery, Haaglanden Medical Center, The Hague, The Netherlands. Electronic address: .
Pokaż więcej
Źródło:
World neurosurgery [World Neurosurg] 2022 Nov; Vol. 167, pp. e639-e647. Date of Electronic Publication: 2022 Aug 24.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*/epidemiology
Neoplasm Recurrence, Local*/surgery
Neoplasm Recurrence, Local*/pathology
Brain Neoplasms*/surgery
Brain Neoplasms*/secondary
Humans ; Female ; Prognosis ; Risk Factors ; Recurrence ; Retrospective Studies
Czasopismo naukowe
Tytuł:
SUCCOR Risk: Design and Validation of a Recurrence Prediction Index for Early-Stage Cervical Cancer.
Autorzy:
Manzour N; Department of Gynecology, Clinica Universidad de Navarra, Pamplona, Spain.
Chiva L; Department of Gynecology, Clinica Universidad de Navarra, Pamplona, Spain. .
Chacón E; Department of Gynecology, Clinica Universidad de Navarra, Pamplona, Spain.
Martin-Calvo N; Department of Preventive Medicine and Public Health, Universidad de Navarra, Pamplona, Spain.
Boria F; Department of Gynecology, Clínica Universidad de Navarra, Madrid, Spain.
Minguez JA; Department of Gynecology, Clinica Universidad de Navarra, Pamplona, Spain.
Alcazar JL; Department of Gynecology, Clinica Universidad de Navarra, Pamplona, Spain.
Pokaż więcej
Corporate Authors:
SUCCOR Study Group
Źródło:
Annals of surgical oncology [Ann Surg Oncol] 2022 Aug; Vol. 29 (8), pp. 4819-4829. Date of Electronic Publication: 2022 Apr 16.
Typ publikacji:
Journal Article; Validation Study
MeSH Terms:
Neoplasm Recurrence, Local*/diagnosis
Neoplasm Recurrence, Local*/pathology
Neoplasm Staging*
Uterine Cervical Neoplasms*/diagnosis
Uterine Cervical Neoplasms*/pathology
Uterine Cervical Neoplasms*/surgery
Female ; Humans ; Hysterectomy/methods ; Prognosis ; Recurrence ; Retrospective Studies ; Risk Assessment
Czasopismo naukowe
Tytuł:
Prediction of Recurrent Cervical Cancer in 2-Year Follow-Up After Treatment Based on Quantitative and Qualitative Magnetic Resonance Imaging Parameters: A Preliminary Study.
Autorzy:
Liu J; Department of MRI, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China. .
Li S; Department of MRI, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
Cao Q; Department of Radiotreatment, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
Zhang Y; Department of MRI, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
Nickel MD; MR Application Predevelopment, Siemens Healthcare GmbH, Erlangen, Germany.
Zhu J; MR Collaboration, Siemens Healthineers Ltd., Xicheng District, Beijing, China.
Cheng J; Department of MRI, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
Pokaż więcej
Źródło:
Annals of surgical oncology [Ann Surg Oncol] 2023 Sep; Vol. 30 (9), pp. 5577-5585. Date of Electronic Publication: 2023 Jun 25.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*/diagnostic imaging
Neoplasm Recurrence, Local*/surgery
Uterine Cervical Neoplasms*/diagnostic imaging
Uterine Cervical Neoplasms*/surgery
Female ; Humans ; Follow-Up Studies ; Prospective Studies ; Magnetic Resonance Imaging/methods ; Retrospective Studies ; Prognosis
Czasopismo naukowe
Tytuł:
Evaluation of mechlorethamine, vinblastine, procarbazine, and prednisone for the treatment of resistant multicentric canine lymphoma.
Autorzy:
Zimmerman K; Department of Clinical Science & Advanced Medicine, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania, USA.
Walsh KA; Department of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania, USA.
Ferrari JT; Surgical Oncology, The Schwarzman Animal Medical Center, New York, New York, USA.
Keuler NS; Department of Statistics, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Atherton MJ; Department of Clinical Science & Advanced Medicine, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania, USA.; Department of Biomedical Sciences, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania, USA.
Lenz JA; Department of Clinical Science & Advanced Medicine, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania, USA.
Pokaż więcej
Źródło:
Veterinary and comparative oncology [Vet Comp Oncol] 2023 Sep; Vol. 21 (3), pp. 503-508. Date of Electronic Publication: 2023 May 24.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*/drug therapy
Neoplasm Recurrence, Local*/veterinary
Dog Diseases*/chemically induced
Lymphoma*/drug therapy
Lymphoma*/veterinary
Lymphoma, Non-Hodgkin*/drug therapy
Lymphoma, Non-Hodgkin*/veterinary
Animals ; Dogs ; Prednisone/therapeutic use ; Vinblastine/therapeutic use ; Mechlorethamine/therapeutic use ; Mechlorethamine/adverse effects ; Vincristine ; Procarbazine/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Doxorubicin/therapeutic use
Czasopismo naukowe
Tytuł:
MRI-derived tumor volume as a predictor of biochemical recurrence and adverse pathology in patients after radical prostatectomy: a propensity score matching study.
Autorzy:
Zhu X; Department of Urology, Peking University Third Hospital, Beijing, China.
Liu Z; Department of Urology, Peking University Third Hospital, Beijing, China.
He J; Department of Urology, Peking University Third Hospital, Beijing, China.
Li Z; Department of Urology, Peking University Third Hospital, Beijing, China.
He W; Department of Radiology, Peking University Third Hospital, Beijing, China.
Lu J; Department of Urology, Peking University Third Hospital, Beijing, China. .
Pokaż więcej
Źródło:
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2023 Sep; Vol. 149 (11), pp. 8853-8861. Date of Electronic Publication: 2023 May 06.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*/pathology
Prostatectomy*
Male ; Humans ; Retrospective Studies ; Tumor Burden ; Propensity Score ; Prostate-Specific Antigen
Czasopismo naukowe
Tytuł:
Tailoring capture-recapture methods to estimate registry-based case counts based on error-prone diagnostic signals.
Autorzy:
Ge L; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
Zhang Y; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
Ward KC; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
Lash TL; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
Waller LA; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
Lyles RH; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
Pokaż więcej
Źródło:
Statistics in medicine [Stat Med] 2023 Jul 30; Vol. 42 (17), pp. 2928-2943. Date of Electronic Publication: 2023 May 09.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Neoplasm Recurrence, Local*
Breast Neoplasms*/diagnosis
Breast Neoplasms*/epidemiology
Humans ; Female ; Bayes Theorem ; Registries ; Epidemiological Monitoring
Czasopismo naukowe
Tytuł:
Immune cells in residual disease and recurrence.
Autorzy:
Ceyhan Y; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Garcia NMG; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Alvarez JV; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA. Electronic address: .
Pokaż więcej
Źródło:
Trends in cancer [Trends Cancer] 2023 Jul; Vol. 9 (7), pp. 554-565. Date of Electronic Publication: 2023 May 05.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Neoplasm Recurrence, Local*/pathology
Tumor Microenvironment*
Humans ; Neoplasm, Residual ; Cell Line, Tumor ; Cell Survival
Czasopismo naukowe
Tytuł:
Harnessing NK cell-based immunotherapy to prevent the high-dose radiotherapy-inducing tumor survival recurrence.
Autorzy:
Xiong Y; Institute of Medical Technology, Peking University Health Science Center; Department of Radiation Oncology, Peking University Third Hospital, Beijing 100191, China.
Jiang P; Institute of Medical Technology, Peking University Health Science Center; Department of Radiation Oncology, Peking University Third Hospital, Beijing 100191, China.
Wei S; Institute of Medical Technology, Peking University Health Science Center; Department of Radiation Oncology, Peking University Third Hospital, Beijing 100191, China.
Li M; Institute of Medical Technology, Peking University Health Science Center; Department of Radiation Oncology, Peking University Third Hospital, Beijing 100191, China.
Yang Y; Institute of Medical Technology, Peking University Health Science Center; Department of Radiation Oncology, Peking University Third Hospital, Beijing 100191, China.
Xiong L; Institute of Medical Technology, Peking University Health Science Center; Department of Radiation Oncology, Peking University Third Hospital, Beijing 100191, China.
Wang J; Institute of Medical Technology, Peking University Health Science Center; Department of Radiation Oncology, Peking University Third Hospital, Beijing 100191, China. Electronic address: junjiewang_.
Li C; Institute of Medical Technology, Peking University Health Science Center; Department of Radiation Oncology, Peking University Third Hospital, Beijing 100191, China. Electronic address: .
Pokaż więcej
Źródło:
International immunopharmacology [Int Immunopharmacol] 2023 Jul; Vol. 120, pp. 110288. Date of Electronic Publication: 2023 May 15.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*/radiotherapy
Killer Cells, Natural*
Animals ; Mice ; Receptors, Immunologic/metabolism ; Cell Line ; Immunotherapy ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Major and minor salivary gland cancers: A multicenter retrospective study.
Autorzy:
Hacioglu MB; Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.
Erdogan B; Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.
Bardakcı M; Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey.
Algın E; Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey.
Gulbagcı B; Department of Medical Oncology, Faculty of Medicine, Sakarya University, Sakarya, Turkey.
Hacibekiroglu I; Department of Medical Oncology, Faculty of Medicine, Sakarya University, Sakarya, Turkey.
Hamdard J; Department of Medical Oncology, Faculty of Medicine, Medipol University, İstanbul, Turkey.
Olmez OF; Department of Medical Oncology, Faculty of Medicine, Medipol University, İstanbul, Turkey.
Akkus H; Department of Medical Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital, Ankara, Turkey.
Oksuzoglu B; Department of Medical Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital, Ankara, Turkey.
Goksu SS; Department of Medical Oncology, Faculty of Medicine, Akdeniz University, Antalya, Turkey.
Dae SA; Department of Medical Oncology, Faculty of Adana Medicine, Baskent University, Adana, Turkey.
Sumbul AT; Department of Medical Oncology, Faculty of Adana Medicine, Baskent University, Adana, Turkey.
Ugraklı M; Department of Medical Oncology, Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey.
Karaagac M; Department of Medical Oncology, Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey.
Sahin E; Department of Medical Oncology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey.
Cabuk D; Department of Medical Oncology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey.
Ozer O; Department of Medical Oncology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
Yavuzsen T; Department of Medical Oncology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
Arıkan R; Department of Medical Oncology, Faculty of Medicine, Marmara University, Istanbul, Turkey.
Köstek O; Department of Medical Oncology, Faculty of Medicine, Marmara University, Istanbul, Turkey.
Atcı MM; Department of Medical Oncology, Prof. Dr. Cemil Tascıoglu City Hospital, Istanbul, Turkey.
Sakin A; Department of Medical Oncology, Prof. Dr. Cemil Tascıoglu City Hospital, Istanbul, Turkey.
Deligonul A; Department of Medical Oncology, Faculty of Medicine, Uludag University, Bursa, Turkey.
Bayır D; Department of Medical Oncology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.
Dincer M; Department of Medical Oncology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.
Unsal O; Department of Medical Oncology, Faculty of Medicine, Gazi University, Ankara, Turkey.
Yazıcı O; Department of Medical Oncology, Faculty of Medicine, Gazi University, Ankara, Turkey.
Zeynelgil E; Department of Medical Oncology, Diskapi Yıldırım Beyazıt Education and Research Hospital, Ankara, Turkey.
Gulmez A; Department of Medical Oncology, Faculty of Medicine, Inonu University, Malatya, Turkey.
Harputluoglu H; Department of Medical Oncology, Faculty of Medicine, Inonu University, Malatya, Turkey.
Erol C; Department of Medical Oncology, Faculty of Medicine, Ankara Yıldırım Beyazit University, Ankara, Turkey.
Sendur MAN; Department of Medical Oncology, Faculty of Medicine, Ankara Yıldırım Beyazit University, Ankara, Turkey.
Aytekin A; Department of Medical Oncology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey.
Akagunduz B; Department of Medical Oncology, Mengucek Gazi Education and Research Hospital, Erzincan Binali Yıldırım University, Erzincan, Turkey.
Oner I; Department of Medical Oncology, Konya City Hospital, Konya, Turkey.
Er O; Department of Medical Oncology, Maslak Hospital, Acıbadem MAA University, Istanbul, Turkey.
Oztosun B; Department of Medical Oncology, Goztepe Education and Research Hospital, Medeniyet University, Istanbul, Turkey.
Gumus M; Department of Medical Oncology, Goztepe Education and Research Hospital, Medeniyet University, Istanbul, Turkey.
Selçukbiricik F; Department of Medical Oncology, Koc University Hospital, Istanbul, Turkey.
Aykan MB; Department of Medical Oncology, Ankara Gulhane Education and Research Hospital, Ankara, Turkey.
Karadurmus N; Department of Medical Oncology, Ankara Gulhane Education and Research Hospital, Ankara, Turkey.
Degerli E; Department of Medical Oncology, Faculty of Medicine, Cerrahpasa University, Istanbul, Turkey.
Demirci NS; Department of Medical Oncology, Faculty of Medicine, Cerrahpasa University, Istanbul, Turkey.
Turkmen E; Department of Medical Oncology, Derince Education and Research Hospital, Kocaeli, Turkey.
Şakalar T; Department of Medical Oncology, Kahramanmaras Necip Fazıl City Hospital, Kahramanmaras, Turkey.
Secmeler S; Department of Medical Oncology, Sanlıurfa Mehmet Akif İnan Education and Research Hospital, Şanlıurfa, Turkey.
Tanrıverdi O; Department of Medical Oncology, Faculty of Medicine, Mugla Sıtkı Kocman University, Mugla, Turkey.
Alkan A; Department of Medical Oncology, Faculty of Medicine, Mugla Sıtkı Kocman University, Mugla, Turkey.
Kemal Y; Department of Medical Oncology, Faculty of Medicine, Altınbas University, Samsun, Turkey.
Cil I; Department of Medical Oncology, Istanbul Umraniye Education and Research Hospital, Istanbul, Turkey.
Unal C; Department of Medical Oncology, Gayrettepe Florence Nightingale Hospital, Istanbul Bilim University, Istanbul, Turkey.
Iriagaç Y; Department of Medical Oncology, Faculty of Medicine, Tekirdag Namık Kemal University, Tekirdag, Turkey.
Alan O; Department of Medical Oncology, Tekirdag City Hospital, Tekirdag, Turkey.
Balli S; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Urun Y; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Ozcan E; Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.
Turhal NS; Department of Medical Oncology, Anadolu Medical Center, Kocaeli, Turkey.
Cicin I; Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.
Pokaż więcej
Źródło:
Head & neck [Head Neck] 2023 Jul; Vol. 45 (7), pp. 1643-1653. Date of Electronic Publication: 2023 Apr 21.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*/epidemiology
Neoplasm Recurrence, Local*/pathology
Salivary Gland Neoplasms*/epidemiology
Salivary Gland Neoplasms*/therapy
Humans ; Retrospective Studies ; Salivary Glands, Minor/pathology
Czasopismo naukowe
Tytuł:
Locally Recurrent Rectal Cancer: Toward a Second Chance at Cure? A Population-Based, Retrospective Cohort Study.
Autorzy:
Swartjes H; Department of Surgery, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands. .
van Rees JM; Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
van Erning FN; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands.; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands.
Verheij M; Department of Radiation Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Verhoef C; Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
de Wilt JHW; Department of Surgery, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Vissers PAJ; Department of Surgery, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands.
Koëter T; Department of Surgery, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Surgery, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands.
Pokaż więcej
Źródło:
Annals of surgical oncology [Ann Surg Oncol] 2023 Jul; Vol. 30 (7), pp. 3915-3924. Date of Electronic Publication: 2023 Feb 15.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*/epidemiology
Neoplasm Recurrence, Local*/therapy
Neoplasm Recurrence, Local*/pathology
Rectal Neoplasms*/epidemiology
Rectal Neoplasms*/therapy
Rectal Neoplasms*/pathology
Humans ; Retrospective Studies ; Rectum/pathology ; Neoadjuvant Therapy
Czasopismo naukowe
Tytuł:
Biochemically recurrent prostate cancer: rationalisation of the approach to imaging.
Autorzy:
Briody H; Department of Medicine, Beaumont Hospital, Dublin, Ireland. Electronic address: .
Sheehan M; Department of Radiology, Beaumont Hospital, Dublin, Ireland.
Hanley M; Department of Radiology, Beaumont Hospital, Dublin, Ireland.
O'Neill B; Department of Radiation Oncology, Beaumont Hospital, Dublin, Ireland.
Dunne R; Department of Radiology, Beaumont Hospital, Dublin, Ireland.
Lee MJ; Department of Radiology, Beaumont Hospital, Dublin, Ireland; Royal College of Surgeons in Ireland, Dublin, Ireland.
Morrin MM; Department of Radiology, Beaumont Hospital, Dublin, Ireland; Royal College of Surgeons in Ireland, Dublin, Ireland.
Pokaż więcej
Źródło:
Clinical radiology [Clin Radiol] 2023 Jul; Vol. 78 (7), pp. 518-524. Date of Electronic Publication: 2023 Apr 05.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*/diagnostic imaging
Neoplasm Recurrence, Local*/surgery
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/surgery
Prostatic Neoplasms*/pathology
Male ; Humans ; Retrospective Studies ; Positron Emission Tomography Computed Tomography/methods ; Prostatectomy ; Gallium Radioisotopes ; Prostate-Specific Antigen
Czasopismo naukowe
Tytuł:
A comparison of mutation and amplification-driven resistance mechanisms and their impacts on tumor recurrence.
Autorzy:
Li A; School of Mathematics, University of Minnesota, Minneapolis, MN, USA.
Kibby D; Target Corporation, Minneapolis, MN, USA.
Foo J; School of Mathematics, University of Minnesota, Minneapolis, MN, USA. .
Pokaż więcej
Źródło:
Journal of mathematical biology [J Math Biol] 2023 Sep 14; Vol. 87 (4), pp. 59. Date of Electronic Publication: 2023 Sep 14.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*/genetics
Aggression*
Humans ; Mutation ; Genomics ; Probability
Czasopismo naukowe
Tytuł:
A systematic review of physical function tests as predictors of key clinical outcomes for adults with blood cancers.
Autorzy:
Ellis R; PGY2 at Moss Rehabilitation Hospital, Elkins Park, USA. .
Blough A; PGY4 at University of Kansas Medical Center, Kansas City, USA.
Clark M; Cancer Rehabilitation Fellowship Director at University of Kansas Medical Center, Kansas City, USA.
Pokaż więcej
Źródło:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2023 Sep 02; Vol. 31 (9), pp. 555. Date of Electronic Publication: 2023 Sep 02.
Typ publikacji:
Systematic Review; Journal Article; Review
MeSH Terms:
Neoplasm Recurrence, Local*
Hematologic Neoplasms*/therapy
Humans ; Adult ; Child ; Medical Oncology ; Clinical Decision-Making ; Data Analysis
Czasopismo naukowe
Tytuł:
Gastroblastoma without GLI1 and EWSR1 gene breaks.
Autorzy:
Gong C; Department of Clinical Pathology, Liuzhou Workers' Hospital, Guangxi, China.
Xu J; Department of Gastrointestinal Surgery, Liuzhou Workers' Hospital, Guangxi, China.
Qiao S; Department of Clinical Pathology, Liuzhou Workers' Hospital, Guangxi, China.
Zhang X; Department of Clinical Pathology, Liuzhou Workers' Hospital, Guangxi, China.
Yi M; Department of Clinical Pathology, Liuzhou Workers' Hospital, Guangxi, China. .
Pokaż więcej
Źródło:
World journal of surgical oncology [World J Surg Oncol] 2023 Sep 01; Vol. 21 (1), pp. 274. Date of Electronic Publication: 2023 Sep 01.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*
Stomach Neoplasms*/genetics
Stomach Neoplasms*/surgery
Female ; Humans ; Male ; Zinc Finger Protein GLI1/genetics ; Retrospective Studies ; RNA-Binding Protein EWS
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies